<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto de Ensino e Pesquisa Albert Einstein</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25946049</article-id>
      <article-id pub-id-type="pmc">4943824</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082015RC2990</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082015RC2990</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Ochoa urofacial syndrome: recognize the peculiar smile and avoid severe urological and renal complications</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rondon</surname>
            <given-names>Atila Victal</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leslie</surname>
            <given-names>Bruno</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Netto</surname>
            <given-names>Jos&#xE9; Murillo Bastos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Freitas</surname>
            <given-names>Ricardo Garcia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ortiz</surname>
            <given-names>Valdemar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Macedo</surname>
            <given-names>Antonio</given-names>
            <suffix>Junior</suffix>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Universidade Federal de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil.</aff>
      <aff id="aff2"><label>2</label>Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.</aff>
      <author-notes>
        <corresp id="c01"><label>Corresponding author</label>: Atila Victal Rondon &#x2212; Rua Maestro Cardim, 560, room 215 &#x2212; Bela Vista &#x2212; Zip code:01323-001 &#x2212; S&#xE3;o Paulo, SP, Brazil &#x2212; Phone: (55 11) 3287-0639 &#x2212; E-mail: <email>atilarondon@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>13</volume>
      <issue>2</issue>
      <fpage>279</fpage>
      <lpage>282</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>9</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Ochoa syndrome is rare and its major clinical problems frequently unrecognized. We describe facial characteristics of six patients to help health professional recognize the inverted smile that these patients present and refer them to proper treatment. Patients&#x2019; medical records were reviewed and patients&#x2019; urological status clinically reassessed. At last evaluation patients&#x2019; mean age was 15.5 years, and age ranged from 12 to 32 years. Mean follow-up was 35 months (12 to 60). Initial symptoms were urinary tract infections in four patients (67%) associated with enuresis and incontinence in three of them (50%). One patient had only urinary tract infection and two lower urinary tract symptoms without infections. Initial treatment consisted of clean intermittent catheterization with anticholinergics for all patients. Four patients (67%) were submitted to bladder augmentation. Two patients had end-stage renal disease during follow-up, one received kidney transplantation and one patient remained on the waiting list for a renal transplantation. Familial consanguinity was present in only one case. This significant condition is rare, but it must be recognized by pediatricians, nephrologists and urologists in order to institute early aggressive urological treatment.</p>
      </abstract>
      <kwd-group>
        <kwd>Urologic diseases/gentics</kwd>
        <kwd>Enuresis</kwd>
        <kwd>Urinary incontinence</kwd>
        <kwd>Lower urinary tract symptoms</kwd>
        <kwd>Urinary bladder, neurogenic</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="10"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The Ochoa syndrome<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> is a rare condition characterized by functional obstructive uropathy and unusual facial abnormalities with a recessive autosomal inheritance pattern. This syndrome ultimately results in upper urinary tract deterioration and eventual renal failure if not diagnosed early.<sup>(<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>)</sup> The Ochoa syndrome is also known as urofacial syndrome that affects both genders and occurs more likely when parents are closely related.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> We retrospectively report on our experience with six patients referred to our institution. Physical examination revealed peculiar facial expression in all patients (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>) and facial grimace when attempting to smile at the time when symptoms started.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Facial pictures of patients 1, 2 and 3, showing the unusual facial expression of grimace when attempting to smile. Note that in the top pictures, patients are in a neutral facial expression while in the bottom line they were asked to smile</title></caption><graphic xlink:href="1679-4508-eins-13-2-0279-gf01"/></fig>
</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Facial pictures of patients 4, 5 and 6, showing the peculiar expression. Top pictures show patients in a neutral facial expression while in the bottom line they were asked to smile</title></caption><graphic xlink:href="1679-4508-eins-13-2-0279-gf02"/></fig>
</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Patient 1 was a 15-year-old girl who had recurrent urinary tract infections (UTIs) since she was 12 years old (<xref rid="f01" ref-type="fig">Figure 1</xref>). She had no history of other urinary tract symptoms and no signs of occult spinal dysraphism. Radiography of lumbosacral region was normal; ultrasound scan revealed bilateral hydronephrosis; urodynamics test showed elevated post-void residual (PVR) urine volume and imercaptosuccinic acid (DMSA); renal scan showed severe bilateral renal scars. Initial management consisted of clean intermittent catheterization (CIC) and use of anticholinergics. Although she lacked other UTI after treatment, a worsening in renal function was noted in the follow-up and currently she is being prepared for renal transplantation.</p>
      <p>
<xref rid="t1" ref-type="table">Table 1</xref> summarizes the clinical information of all patients.</p>
      <p>
<table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Characteristics of six patients</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Follow-up (months)</th><th rowspan="1" colspan="1">Age at initial management (years)</th><th rowspan="1" colspan="1">Present age at the moment of the study (years)</th><th rowspan="1" colspan="1">Gender</th><th rowspan="1" colspan="1">Parents consanguinity</th><th rowspan="1" colspan="1">Initial symptoms</th><th rowspan="1" colspan="1">Renal impairment</th><th rowspan="1" colspan="1">UTI</th><th rowspan="1" colspan="1">Surgery</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">Cousins</td><td align="center" rowspan="1" colspan="1">UTI</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Waiting for renal transplantation</td></tr><tr><td rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">UTI</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Bilateral ureterostomies</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Bladder augmentation</td></tr><tr><td rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">UTI</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Bladder augmentation</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Incontinence</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Enuresis</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Urgency</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">Urgency</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">UTI</td><td align="center" rowspan="1" colspan="1">Left kidney</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Left nephrectomy + bladder augmentation</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Incontinence</td><td align="center" rowspan="1" colspan="1">Kidney</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">Incontinence</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">Mitrofanoff</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Enuresis</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Bladder augmentation</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Renal transplant</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>F: female; UTI: urinary tract infections; M: male.</p></fn></table-wrap-foot></table-wrap>
</p>
      <p>Patient 2 was a 32-year-old man with history of recurrent UTIs in childhood (<xref rid="f01" ref-type="fig">Figure 1</xref>). Urinary tract investigation, while he was followed at another care center, showed dysfunctional voiding and the initial diagnosis was non-neurogenic bladder. Despite the initial management he underwent bilateral ureterostomies at age 4 years old, which successfully keep him free of infection. At the age 9 years old, the ureterostomies were closed and CIC was started but bladder augmentation using a transverse colon was necessary.</p>
      <p>Patient 2 family history was negative for Ochoa syndrome and his parents were not consanguineous. He was 32 years old at the moment we carried out this study and continued on anticholinergics therapy and CIC every 4 hours, remaining without infection. His upper urinary tract was scar free despite the history of UTIs.</p>
      <p>Patients 3 and 4 were siblings aged 16 and 13 years old, respectively. Their parents were not consanguineous and did not have history of urofacial syndrome on the family before. Patient 3 was a 16-year-old boy who was referred to our clinic for recurrent UTIs, dysfunctional voiding, daytime urinary incontinence, enuresis and urgency (<xref rid="f01" ref-type="fig">Figure 1</xref>). Results of ultrasound scan revealed left hydronephrosis, trabeculated bladder and diverticula, and urodynamics test showed a poorly compliant bladder, elevated PVR volume and detrusor-sphincter dyssynergia. The patient had a trabeculated bladder of small capacity and left high-grade vesico-ureteral reflux (VUR) in voiding cystourethrography (VCUG). Initial management consisted of CIC and oxybutynin. Because of anticholinergic side effects, the tolterodine was introduced with partial success. Continence interval was only 1 hour and 30 minutes. Subsequently, he had undergone bladder augmentation with ileum and continued on CIC every 5 hours without any leakage.</p>
      <p>Patient 4 was a 13-year-old girl (<xref rid="f02" ref-type="fig">Figure 2</xref>) who presented urgency and enuresis but without any episodes of UTI. Results of ultrasound scan demonstrated a normal urinary tract, VCUG showed no reflux, normal bladder with large capacity and PVR of 80mL. In addition, urodynamics test showed a poorly compliant bladder, detrusor overactivity and dysfunctional voiding with sphincter dyssynergia.</p>
      <p>To patient 4 an early management was proposed to avoid deterioration of upper urinary tract. She successfully underwent CIC and anticholinergics therapy. Currently, she remained well adapted to CIC, continence interval of 6 hours and with upper urinary tract preserved.</p>
      <p>Patient 5 was a 12-year-old boy with daytime incontinence, recurrent UTIs, lumbar pain and an episode of urinary retention (<xref rid="f02" ref-type="fig">Figure 2</xref>). At physical examination no sings of occult spinal dysraphism were found. Ultrasound scan revealed left ureterohydronephrosis and thick-walled bladder. In addition, he had a trabeculated bladder with diverticula and left high-grade VUR found in VCUG. Urodynamics test showed a poorly compliant bladder, detrusor-sphincter dyssynergia and elevated PVR volume. DMSA demonstrated severe scaring on left kidney.</p>
      <p>Initial management consisted of CIC and anticholinergics but due to discomfort during urethral CIC, the treatment compliance was compromised. The patient had febrile UTIs and worsening of left renal function. He underwent left nephrectomy and a bladder augmentation with ileum and continued with CIC every 4 hours, no leakage was observed. Patient&#x2019;s right kidney was preserved.</p>
      <p>Patient 6 was a 16 year-old boy (<xref rid="f02" ref-type="fig">Figure 2</xref>) whose 7 siblings were normal. A history of recurrent UTIs and dysfunctional voiding was noted with elevated PVR volumes. Urodinamics test showed a poorly compliant bladder, elevated PVR volume and detrusor-sphincter dyssynergia. He was followed at another center and had undergone an appendicovesicostomy when he was 7 years old. CIC and anticholinergics therapy were administered that decreased episodes of UTIs.</p>
      <p>After 6 years, he had hypertension and was referred to the nephrology clinic for evaluation. He also had moderate renal impairment with an inadequate response to antihypertensive drugs. Results of ultrasound scan revealed bilateral ureterohydronephrosis, thick-walled bladder and a small left kidney. VCUG showed bilateral VUR and a small trabeculated bladder. DMSA demonstrated bilateral renal scarring with severe right kidney impairment. The patient underwent a bladder augmentation with ileum and was kept under CIC. After a 3-year follow-up he had a severe renal impairment and received a cadaver donor renal transplantation.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Bernardo Ochoa described a group of children with symptoms of neurogenic bladder (enuresis, incontinence, UTI, constipation, trabeculated bladder and vesicoureteral reflux), but with neither apparent neurological condition nor mechanical obstructive abnormalities that could justify the urological findings.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
      <p>These cases would be classified as non-neurogenic neurogenic bladder as previously described by Hinman<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> if a peculiar finding on their facial expression was not present. Ochoa noticed that children who participated in the study showed a pathognomonic inversion of the facial expression such as facial grimace or cry when they attempted to smile. For this reason, he proposed the name &#x201C;urofacial syndrome&#x201D;.</p>
      <p>Recent studies have localized the defective gene for urofacial syndrome in a region on chromosome 10q23-q24, with evidence of mutations on Heparanase 2 (HPSE2) gene that would be responsible for this syndrome.<sup>(<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B9" ref-type="bibr">9</xref>)</sup> Although the exactly biological function has not yet been established, complete loss of HPSE2 function in patients with urofacial syndrome suggests it may be implicated on the genesis of the syndrome.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> The gene seems to be transmitted in a recessive autosomal inheritance pattern.</p>
      <p>In the upper pons of the midbrain are located the crying and laughing centers, very close to the micturition center, and this proximity could explain how a neurologic lesion may affect both regions simultaneously,<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> but this theory has not been proved yet. Many of these patients are not diagnosed and the lack of appropriate treatment results in upper urinary tract injury and ultimately renal failure.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>
</p>
      <p>Early diagnosis is then essential to achieve a better prognosis. An aggressive urological management is necessary to improve bladder emptying and avoid infections. The suspicious must be raised when observed the combination of urological problems and inverted facial expression upon attempts to smile.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup>
</p>
      <p>This experience justifies the need to communicate and educate health professions about this syndrome, the picture of patients&#x2019; smile is self-explanatory. Pediatricians, nephrologists and urologists should be aware of the relationship between voiding symptoms and this peculiar facial sign.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ochoa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gorlin</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Urofacial (ochoa) syndrome</article-title>
          <source>Am J Med Genet</source>
          <year>1987</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>661</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="pmid">3631137</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aydogdu</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Burgu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Demirel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Soygur</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ozcakar</surname>
              <given-names>ZB</given-names>
            </name>
            <name>
              <surname>Yalcinkaya</surname>
              <given-names>F</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Ochoa syndrome: a spectrum of urofacial syndrome</article-title>
          <source>Eur J Pediatr</source>
          <year>2010</year>
          <volume>169</volume>
          <issue>4</issue>
          <fpage>431</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">19669792</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicanor</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pippi-Salle</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Early diagnosis of the urofacial syndrome is essential to prevent irreversible renal failure</article-title>
          <source>Int Braz J Urol</source>
          <year>2005</year>
          <volume>31</volume>
          <issue>5</issue>
          <fpage>477</fpage>
          <lpage>481</lpage>
          <pub-id pub-id-type="pmid">16255797</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ochoa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Can a congenital dysfunctional bladder be diagnosed from a smile? The Ochoa syndrome updated</article-title>
          <source>Pediatr Nephrol</source>
          <year>2004</year>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>6</fpage>
          <lpage>12</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">14648341</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinman</surname>
              <given-names>F</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Nonneurogenic neurogenic bladder (the Hinman syndrome)--15 years later</article-title>
          <source>J Urol</source>
          <year>1986</year>
          <volume>136</volume>
          <issue>4</issue>
          <fpage>769</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="pmid">3761428</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hawkins-Lee</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome</article-title>
          <source>Am J Hum Genet</source>
          <year>2010</year>
          <volume>86</volume>
          <issue>6</issue>
          <fpage>957</fpage>
          <lpage>962</lpage>
          <comment>Erratum in: Am J Hum Genet. 2010;87(1):161. Fischer, Richard B [added]</comment>
          <pub-id pub-id-type="pmid">20560209</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahmood</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Beetz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tahir</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Imran</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mumtaz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bassmann</surname>
              <given-names>I</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>First HPSE2 missense mutation in urofacial syndrome</article-title>
          <source>Clin Genet</source>
          <year>2012</year>
          <volume>81</volume>
          <issue>1</issue>
          <fpage>88</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">21332471</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daly</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Urquhart</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Hilton</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Kammerer</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Mutations in HPSE2 cause urofacial syndrome</article-title>
          <source>Am J Hum Genet</source>
          <year>2010</year>
          <volume>86</volume>
          <issue>6</issue>
          <fpage>963</fpage>
          <lpage>969</lpage>
          <comment>Erratum in: Am J Hum Genet. 2010;87(2):309</comment>
          <pub-id pub-id-type="pmid">20560210</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al Badr</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Al Bader</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hildebrandt</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ackley</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>W</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Exome capture and massively parallel sequencing identifies a novel HPSE2 mutation in a Saudi Arabian child with Ochoa (urofacial) syndrome</article-title>
          <source>J Pediatr Urol</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>569</fpage>
          <lpage>573</lpage>
          <pub-id pub-id-type="pmid">21450525</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Derbent</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Melek</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Arman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>U&#xE7;kan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baskin</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Urofacial (ochoa) syndrome: can a facial gestalt represent severe voiding dysfunction?</article-title>
          <source>Ren Fail</source>
          <year>2009</year>
          <volume>31</volume>
          <issue>7</issue>
          <fpage>589</fpage>
          <lpage>592</lpage>
          <pub-id pub-id-type="pmid">19839856</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="TRpt" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>S&#xED;ndrome urofacial de Ochoa: reconhe&#xE7;a o sorriso peculiar e evite complica&#xE7;&#xF5;es urol&#xF3;gicas e renais graves</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rondon</surname>
            <given-names>Atila Victal</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leslie</surname>
            <given-names>Bruno</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Netto</surname>
            <given-names>Jos&#xE9; Murillo Bastos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freitas</surname>
            <given-names>Ricardo Garcia de</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ortiz</surname>
            <given-names>Valdemar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Macedo</surname>
            <given-names>Antonio</given-names>
            <suffix>Junior</suffix>
          </name>
          <xref ref-type="aff" rid="aff1002">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1002"><label>1</label>Universidade Federal de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brasil.</aff>
      <aff id="aff2002"><label>2</label>Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brasil.</aff>
      <author-notes>
        <corresp id="c01002"> Autor correspondente: Atila Victal Rondon &#x2212; Rua Maestro Cardim, 560, conjunto 215 - Bela Vista &#x2212; CEP: 01323-001 &#x2212; S&#xE3;o Paulo, SP, Brasil &#x2212; Tel.: (11) 3287-0639 &#x2212; E-mail: atilarondon@hotmail.com </corresp>
      </author-notes>
      <abstract>
        <p>A s&#xED;ndrome de Ochoa &#xE9; rara, e seus principais problemas cl&#xED;nicos s&#xE3;o frequentemente n&#xE3;o reconhecidos. Descrevem-se aqui caracter&#xED;sticas faciais de seis pacientes para auxiliar profissionais de sa&#xFA;de a reconhecer o sorriso invertido que eles apresentam e encaminh&#xE1;-los para o tratamento adequado. Os prontu&#xE1;rios m&#xE9;dicos foram revisados e a condi&#xE7;&#xE3;o urol&#xF3;gica dos pacientes foi reavaliada clinicamente. A m&#xE9;dia de idade na &#xFA;ltima avalia&#xE7;&#xE3;o foi de 15,5 anos, variando de 12 a 32 anos. O seguimento m&#xE9;dio foi de 35 meses (12 a 60). Os sintomas iniciais foram infec&#xE7;&#xF5;es do trato urin&#xE1;rio em quatro pacientes (67%) associadas com enurese e incontin&#xEA;ncia urin&#xE1;ria em tr&#xEA;s deles (50%). Um paciente apresentou infec&#xE7;&#xF5;es do trato urin&#xE1;rio isoladamente e dois apresentaram sintomas do trato urin&#xE1;rio inferior, por&#xE9;m sem infec&#xE7;&#xF5;es. O tratamento inicial consistiu em cateterismo intermitente limpo, com anticolin&#xE9;rgicos em todos os pacientes. Reconstru&#xE7;&#xE3;o urin&#xE1;ria foi realizada em quatro pacientes (67%) por meio de amplia&#xE7;&#xE3;o vesical. Dois pacientes apresentaram doen&#xE7;a renal em est&#xE1;gio terminal no seguimento, um recebeu transplante renal e outro manteve-se em lista de espera para transplante renal. Consanguinidade familiar esteve presente em apenas um caso. Essa condi&#xE7;&#xE3;o significativa &#xE9; rara, por&#xE9;m deve ser reconhecida por pediatras, nefrologistas e urologistas, a fim de instituir tratamento urol&#xF3;gico agressivo precoce.</p>
      </abstract>
      <kwd-group>
        <kwd>Doen&#xE7;as urol&#xF3;gicas/gen&#xE9;tica</kwd>
        <kwd>Enurese</kwd>
        <kwd>Incontin&#xEA;ncia urin&#xE1;ria</kwd>
        <kwd>Sintomas do trato urin&#xE1;rio inferior</kwd>
        <kwd>Bexiga urin&#xE1;ria neurog&#xEA;nica</kwd>
        <kwd>Relatos de Casos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>A s&#xED;ndrome de Ochoa<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> &#xE9; uma condi&#xE7;&#xE3;o rara caracterizada pela uropatia obstrutiva funcional e por anormalidades faciais incomuns, com padr&#xE3;o de heran&#xE7;a autoss&#xF4;mica recessiva. Essa s&#xED;ndrome resulta em deteriora&#xE7;&#xE3;o do trato urin&#xE1;rio superior e em eventual insufici&#xEA;ncia renal, se n&#xE3;o diagnosticada precocemente.<sup>(<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>)</sup> A s&#xED;ndrome de Ochoa &#xE9; tamb&#xE9;m conhecida como s&#xED;ndrome urofacial e afeta ambos os sexos, por&#xE9;m ocorre com maior frequ&#xEA;ncia quando os pais s&#xE3;o consangu&#xED;neos.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> Relata-se retrospectivamente experi&#xEA;ncia com seis pacientes encaminhados a nossa institui&#xE7;&#xE3;o. O exame f&#xED;sico revelou express&#xE3;o facial peculiar em todos os pacientes (<xref ref-type="fig" rid="f01002">Figuras 1</xref> e <xref ref-type="fig" rid="f02002">2</xref>) e anormalidade da m&#xED;mica facial na tentativa de sorrir, no momento em que os sintomas iniciam.</p>
        <p>
<fig id="f01002" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Imagens dos pacientes 1, 2 e 3, mostrando express&#xE3;o facial incomum de careta quando na tentativa de sorrir. Note que, nas imagens superiores, os pacientes est&#xE3;o com express&#xE3;o facial neutra, enquanto nas imagens inferiores foram solicitados a sorrir</title></caption><graphic xlink:href="1679-4508-eins-13-2-0279-gf01-pt"/></fig>
</p>
        <p>
<fig id="f02002" orientation="portrait" position="float"><label>Figura 2</label><caption><title>Imagens de express&#xE3;o facial dos pacientes 4, 5 e 6, mostrando express&#xE3;o peculiar. As imagens superiores mostram express&#xE3;o facial neutra, enquanto as imagens inferiores quando foram solicitados a sorrir</title></caption><graphic xlink:href="1679-4508-eins-13-2-0279-gf02-pt"/></fig>
</p>
      </sec>
      <sec>
        <title>RELATO DE CASO</title>
        <p>Paciente 1, de 15 anos, sexo feminino, apresentava frequentes infec&#xE7;&#xF5;es do trato urin&#xE1;rio (ITUs) desde os 12 anos de idade (<xref rid="f01002" ref-type="fig">Figura 1</xref>). Al&#xE9;m disso, n&#xE3;o possu&#xED;a hist&#xF3;rico de outros sintomas no trato urin&#xE1;rio e nem sinais de disrafismo espinhal oculto. A radiografia da regi&#xE3;o lombossacral era normal; a ultrassonografia revelou hidronefrose bilateral; o exame urodin&#xE2;mico mostrou res&#xED;duo miccional elevado e &#xE1;cido mercaptosuccinico (DMSA); o renograma apresentou cicatrizes renais bilaterais graves. O tratamento inicial consistiu em cateteriza&#xE7;&#xE3;o intermitente limpa (CIL) e no uso de anticolin&#xE9;rgicos. Apesar de a paciente n&#xE3;o apresentar outra ITU ap&#xF3;s o tratamento, uma piora na fun&#xE7;&#xE3;o renal foi notada durante seguimento e, no momento deste estudo, ela se preparava para transplante renal.</p>
        <p>A <xref rid="t1002" ref-type="table">tabela 1</xref> resume as informa&#xE7;&#xF5;es cl&#xED;nicas de todos os pacientes.</p>
        <p>
<table-wrap id="t1002" orientation="portrait" position="float"><label>Tabela 1</label><caption><title>Caracter&#xED;sticas de seis pacientes</title></caption><table frame="hsides" rules="groups"><colgroup width="10%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Paciente</th><th rowspan="1" colspan="1">Seguimento (meses)</th><th rowspan="1" colspan="1">Idade no tratamento inicial (anos)</th><th rowspan="1" colspan="1">Idade no momento do estudo (anos)</th><th rowspan="1" colspan="1">G&#xEA;nero</th><th rowspan="1" colspan="1">Pais consangu&#xED;neos</th><th rowspan="1" colspan="1">Sintomas iniciais</th><th rowspan="1" colspan="1">Les&#xE3;o renal</th><th rowspan="1" colspan="1">ITU</th><th rowspan="1" colspan="1">Cirurgia</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">Primos</td><td align="center" rowspan="1" colspan="1">ITU</td><td align="center" rowspan="1" colspan="1">Sim</td><td align="center" rowspan="1" colspan="1">Sim</td><td align="center" rowspan="1" colspan="1">Espera por transplante renal</td></tr><tr><td rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">ITU</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">Sim</td><td align="center" rowspan="1" colspan="1">Ureterostomia bilateral</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Aumento da bexiga</td></tr><tr><td rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">ITU</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">Sim</td><td align="center" rowspan="1" colspan="1">Aumento da bexiga</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Incontin&#xEA;ncia</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Enurese</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Urg&#xEA;ncia</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">Urg&#xEA;ncia</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Enurese</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">ITU</td><td align="center" rowspan="1" colspan="1">Rim esquerdo</td><td align="center" rowspan="1" colspan="1">Sim</td><td align="center" rowspan="1" colspan="1">Nefrectomia esquerda + aumento da bexiga</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Incontin&#xEA;ncia</td><td align="center" rowspan="1" colspan="1">Rim</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td></tr><tr><td rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">Incontin&#xEA;ncia</td><td align="center" rowspan="1" colspan="1">Sim</td><td align="center" rowspan="1" colspan="1">N&#xE3;o</td><td align="center" rowspan="1" colspan="1">Mitrofanoff</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Enurese</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Aumento da bexiga</td></tr><tr><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td rowspan="1" colspan="1">&#xA0;</td><td align="center" rowspan="1" colspan="1">Transplante renal</td></tr></tbody></table><table-wrap-foot><fn id="TFN1002"><p>F: feminino; ITU: infec&#xE7;&#xE3;o do trato urin&#xE1;rio; M: masculino.</p></fn></table-wrap-foot></table-wrap>
</p>
        <p>O paciente 2, de 32 anos, sexo masculino, tinha hist&#xF3;rico de ITUs recorrentes na inf&#xE2;ncia (<xref rid="f01002" ref-type="fig">Figura 1</xref>). Foi realizada investiga&#xE7;&#xE3;o do trato urin&#xE1;rio enquanto o paciente foi assistido em outro centro, que mostrou mic&#xE7;&#xE3;o disfuncional e diagn&#xF3;stico inicial de bexiga n&#xE3;o neurog&#xEA;nica. Apesar da conduta inicial, o paciente foi submetido a ureterostomia bilateral aos 4 anos de idade, que o manteve sem infec&#xE7;&#xE3;o com sucesso. Aos 9 anos de idade, as ureterostomias foram fechadas e a CIL foi iniciada, por&#xE9;m foi necess&#xE1;rio o aumento da bexiga utilizando o c&#xF3;lon transverso.</p>
        <p>O hist&#xF3;rico familiar do paciente 2 foi negativo para s&#xED;ndrome de Ochoa, e seus pais n&#xE3;o eram consangu&#xED;neos. Aos 32 anos, o paciente continuava em terapia com anticolin&#xE9;rgicos e CIL a cada 4 horas, o que o mant&#xE9;m livre de infec&#xE7;&#xE3;o. Al&#xE9;m disso, ele n&#xE3;o possu&#xED;a cicatrizes no trato urin&#xE1;rio superior, apesar do hist&#xF3;rico de ITUs.</p>
        <p>Os pacientes 3 e 4 eram irm&#xE3;os, com 16 e 13 anos, respectivamente. Seus pais n&#xE3;o eram consangu&#xED;neos e n&#xE3;o possu&#xED;am hist&#xF3;rico anterior de s&#xED;ndrome urofacial na fam&#xED;lia. Paciente 3 de 16 anos, do sexo masculino, foi encaminhado a nossa cl&#xED;nica devido a ITUs recorrentes, mic&#xE7;&#xE3;o disfuncional, incontin&#xEA;ncia urin&#xE1;ria pela manh&#xE3;, enurese e urg&#xEA;ncia (<xref rid="f01002" ref-type="fig">Figura 1</xref>). Os resultados da ultrassonografia revelaram hidronefrose esquerda, bexiga trabeculada e divert&#xED;culo. O exame urodin&#xE2;mico mostrou bexiga com baixa complac&#xEA;ncia, volume residual p&#xF3;s-miccional (RPM e volume miccional elevados, e dissinergia detrusor-esfincteriana. O paciente apresentava bexiga trabeculada com pequena capacidade e refluxo vesicureteral (RVU) de alto grau em cisturetrografia miccional (CUGM). A conduta inicial foi CIL e oxibutinina. Devido aos efeitos colaterais anticolin&#xE9;rgicos, a tolterodina foi introduzida com sucesso parcial. O intervalo de contin&#xEA;ncia foi de apenas 1 hora e 30 minutos. Subsequentemente, o paciente foi submetido ao aumento da bexiga com al&#xE7;a ileal, e a CIL foi mantida a cada 5 horas sem extravasamento.</p>
        <p>Paciente 4, de 13 anos (<xref rid="f02002" ref-type="fig">Figura 2</xref>), sexo feminino, apresentava urg&#xEA;ncia e enurese, mas com aus&#xEA;ncia de epis&#xF3;dios de ITU. Os resultados da ultrassonografia demostraram trato urin&#xE1;rio normal; CUGM n&#xE3;o mostrou refluxo, bexiga normal com grande capacidade e volume RPM de 80mL. Al&#xE9;m disso, o exame urodin&#xE2;mico mostrou bexiga com baixa complac&#xEA;ncia, atividade excessiva do detrusor e mic&#xE7;&#xE3;o disfuncional com dissinergia do esf&#xED;ncter.</p>
        <p>Para essa paciente, foi proposta conduta pr&#xE9;via para evitar deteriora&#xE7;&#xE3;o do trato urin&#xE1;rio superior. Ela realizou CIL com sucesso e terapia com anticolin&#xE9;rgicos. A paciente permaneceu bem adaptada &#xE0; CIL, apresentando intervalo de contin&#xEA;ncia de 6 horas e com trato urin&#xE1;rio superior preservado.</p>
        <p>Paciente 5, de 12 anos, sexo masculino, apresentava incontin&#xEA;ncia urin&#xE1;ria durante o dia, ITUs recorrentes, dor lombar e epis&#xF3;dios de reten&#xE7;&#xE3;o urin&#xE1;ria (<xref rid="f02002" ref-type="fig">Figura 2</xref>). Em exame f&#xED;sico n&#xE3;o foram encontrados sinais de disrafismo espinhal oculto. A ultrassonografia revelou sinais de ureterohidronefrose esquerda e bexiga apresentando parede espessa. Al&#xE9;m disso, o paciente possu&#xED;a bexiga trabeculada com divert&#xED;culo e RVU &#xE0; esquerda de alto grau encontrada em CUGM. O exame urodin&#xE2;mico mostrou bexiga com baixa complac&#xEA;ncia, dissinergia detrusor-esfincteriana e volume de RPM elevado. DMSA mostrou cicatriza&#xE7;&#xE3;o grave no rim esquerdo.</p>
        <p>A abordagem inicial consistiu de CIL e anticolin&#xE9;rgicos, por&#xE9;m, devido ao desconforto durante CIL uretral, a ades&#xE3;o ao tratamento foi comprometida. O paciente teve febre devido &#xE0;s ITUs e piora da fun&#xE7;&#xE3;o do rim esquerdo. Al&#xE9;m disso, realizou nefrectomia esquerda e apresentou aumento da bexiga com al&#xE7;a ileal; CIL continuou a cada 4 horas, sem que fosse observado extravasamento. O rim esquerdo desse paciente estava preservado.</p>
        <p>O paciente 6, de 16 anos de idade (<xref rid="f02002" ref-type="fig">Figura 2</xref>), possu&#xED;a 7 irm&#xE3;os sadios. O hist&#xF3;rico de ITU recorrente e mic&#xE7;&#xE3;o disfuncional foi notado com volume de RPM elevado. O exame urodin&#xE2;mico mostrou bexiga com baixa complac&#xEA;ncia, volume de RPM elevado e dissinergia detrusor-esfincteriana. O paciente foi acompanhado em outro centro e realizou apendicovesicostomia aos 7 anos de idade. CIL e terapia com anticolin&#xE9;rgico foram administradas, reduzindo, assim, os epis&#xF3;dios de ITUs.</p>
        <p>Ap&#xF3;s 6 anos, o paciente teve hipertens&#xE3;o e foi encaminhado a cl&#xED;nica de nefrologia para avalia&#xE7;&#xE3;o. Ele tamb&#xE9;m teve insufici&#xEA;ncia renal moderada com resposta inadequada a drogas anti-hipertensivas. Os resultados da ultrassonografia revelaram ureterohidronefrose bilateral, espessamento da parede da bexiga e rim esquerdo reduzido. CUGM mostrou RVU e bexiga trabeculada e reduzida. O DMSA mostrou cicatriza&#xE7;&#xE3;o renal bilateral com les&#xE3;o no rim direito. O paciente realizou aumento da bexiga com al&#xE7;a ileal e foi mantido em CIL. Ap&#xF3;s 3 anos de seguimento, apresentou les&#xE3;o renal grave e foi submetido a transplante renal de doador cad&#xE1;ver. Al&#xE9;m disso, realizou aumento da bexiga com al&#xE7;a ileal e foi mantido em CIL.</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>Bernaro Ochoa descreveu um grupo de crian&#xE7;as com sintomas de bexiga neurog&#xEA;nica (enurese, incontin&#xEA;ncia, ITUs, constipa&#xE7;&#xE3;o, bexiga trabeculada e RVU), por&#xE9;m sem condi&#xE7;&#xE3;o neurol&#xF3;gica aparente e nem anormalidades de obstru&#xE7;&#xE3;o mec&#xE2;nica que poderiam justificar o achado urol&#xF3;gico.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
        <p>Esses casos seriam classificados como bexiga n&#xE3;o neurog&#xEA;nica como descrito anteriormente por Hinman,<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> no caso de aus&#xEA;ncia de achado peculiar na express&#xE3;o facial desses pacientes. Ochoa notou que as crian&#xE7;as que participaram no estudo mostraram uma invers&#xE3;o patognom&#xF4;nica da express&#xE3;o facial, tal como careta ou choro, quando tentavam sorrir. Por esse motivo, o nome &#x201C;s&#xED;ndrome orofacial&#x201D; foi proposto.</p>
        <p>Estudos recentes t&#xEA;m localizado o gene defeituoso para s&#xED;ndrome urofacial na regi&#xE3;o no cromossomo 10q23-q24, com evid&#xEA;ncia de muta&#xE7;&#xF5;es na Heparanase 2 (HPSE2); o gene que seria respons&#xE1;vel por essa s&#xED;ndrome.<sup>(<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B9" ref-type="bibr">9</xref>)</sup> Apesar de a fun&#xE7;&#xE3;o biol&#xF3;gica exata ainda n&#xE3;o estar estabelecida, a perda completa da fun&#xE7;&#xE3;o do HPSE2 em pacientes com s&#xED;ndrome urofacial sugere que pode implicar na g&#xEA;nesis da s&#xED;ndrome.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> O gene parece ser transmitido em padr&#xE3;o de heran&#xE7;a autoss&#xF4;mica recessiva.</p>
        <p>Nas protuber&#xE2;ncias superiores do mesenc&#xE9;falo est&#xE3;o localizados os centros de choro e riso, muito pr&#xF3;ximos do centro da mic&#xE7;&#xE3;o. Portanto, essa proximidade pode explicar como a les&#xE3;o neurol&#xF3;gica pode afetar ambas as regi&#xF5;es simultaneamente,<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> mas essa teoria ainda n&#xE3;o foi comprovada. Muitos desses pacientes n&#xE3;o s&#xE3;o diagnosticados, al&#xE9;m da falta de resultados e tratamento apropriados na les&#xE3;o do trato urin&#xE1;rio superior e insufici&#xEA;ncia renal.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>
</p>
        <p>O diagn&#xF3;stico precoce &#xE9; essencial para atingir um melhor progn&#xF3;stico. Tratamento urol&#xF3;gico agressivo &#xE9; necess&#xE1;rio para melhorar o esvaziamento da bexiga e evitar infec&#xE7;&#xF5;es. As suspeitas devem ser levantadas quando observada a combina&#xE7;&#xE3;o entre problemas urol&#xF3;gicos e a express&#xE3;o facial invertida quando da tentativa de sorrir.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup>
</p>
        <p>Essa experi&#xEA;ncia justifica a necessidade de informar e educar profissionais de sa&#xFA;de em rela&#xE7;&#xE3;o a essa s&#xED;ndrome. A imagem do sorriso dos pacientes &#xE9; autoexplicativa. Pediatras, nefrologistas e urologistas devem conhecer o relacionamento entre sintomas miccionais e sinal facial peculiar.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
